NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 77 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $152,000 | -41.3% | 114,066 | +0.3% | 0.00% | -50.0% |
Q3 2015 | $259,000 | +65.0% | 113,678 | +16.6% | 0.00% | +100.0% |
Q2 2015 | $157,000 | -24.9% | 97,453 | -25.9% | 0.00% | -50.0% |
Q1 2015 | $209,000 | -16.4% | 131,489 | -0.4% | 0.00% | 0.0% |
Q4 2014 | $250,000 | +43.7% | 132,057 | 0.0% | 0.00% | +100.0% |
Q3 2014 | $174,000 | +5700.0% | 132,057 | +7502.6% | 0.00% | – |
Q2 2014 | $3,000 | -98.4% | 1,737 | -98.3% | 0.00% | -100.0% |
Q1 2014 | $189,000 | -10.4% | 102,004 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $211,000 | -21.9% | 102,004 | 0.0% | 0.00% | -50.0% |
Q3 2013 | $270,000 | +103.0% | 102,004 | +104.8% | 0.00% | +100.0% |
Q2 2013 | $133,000 | – | 49,814 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |